Title: Major Histocompatibility Complex MHC
1Major Histocompatibility Complex(MHC)
- What is MHC?
- HLA
- H-2
- Minor histocompatibility antigens
2Progress in organ transplantation
3Significance of the MHC
- role in immune response
- role in organ transplantation
- role in predisposition to disease
4Genetic barriers to transplantation
- autologous in the same individual
- isologous between genetically Identical
individuals, i.e., identical twins (inbred
animals) - homologous between individuals of the same
species - heterologous between individuals different
species
5The laws of transplantation
6Histocompatibility antigensand graft survival
- minor histocompatibility antigens also cause
rejection - The rejection time is variable but shorter than
that for major histocompatibility antigen - They have additive effects
7Graft versus host disease
8Graft versus host disease
9The human MHC genes
10The mouse MHC genes
11Polymorphism of MHC genes
12The inheritance of MHC genes
13MHC products expressed on cells
14Crossing overresults in new haplotypes
15Differential expression of MHC antigens
- Class-I expressed on all nucleated cells in man,
and also on erythrocytes in mice.
- Class-II expressed primarily on antigen
presenting cells (dendritic cells, macrophages
and B cells)
16Cytotoxic T lymphocyte (CTL) generation
17Alloreactivity of T cells
Alloreaction (MLR)
Thymus
Positive Selection
Proliferation and Differentiation
18Mechanisms of graft rejection
Inflammation
ADCC
lysis
rejection
19Tempo of rejection reaction
type of rejection
cause
time taken
minutes- hours
preformed anti-donor antibodies and complement
hyperacute
reactivation of sensitized T cells (secondary
response)
days
accelerated
primary activation of T cells
acute
days-weeks
unclear causes cross reactive Ab, immune
complexes, slow cellular reaction, tolerance
breakdown, disease recurrence
months-years
chronic
20HLA matching and graft survival
21Blood transfusion and graft survival
22Immunosuppresseive agents
23Immunosuppresseive agents
24Removal of T cells from marrow graft
Magnetic antibodies
25HLA and disease association
26Organ transplant activityUSA, 1988
27Serological tissue typingthe scheme
28Tissue typing by themixed lymphocyte reaction
(MLR)
29Tissue typingthe MLR scheme
30Lymphocyte proliferation during MLR